Cargando…

Microbicides & their implications in HIV prevention

Detalles Bibliográficos
Autores principales:	Karim, Salim S. Abdool, Baxter, Cheryl
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102450/ https://www.ncbi.nlm.nih.gov/pubmed/21245610

Ejemplares similares

Mechanisms of sexually transmitted infection‐induced inflammation in women: implications for HIV risk
por: Mwatelah, Ruth, et al.
Publicado: (2019)

Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide
por: Ngandu, Nobubelo K., et al.
Publicado: (2017)

Microbicides for HIV prevention
por: Ramjee, Gita
Publicado: (2011)

Current status of the HIV epidemic & challenges in prevention
por: Karim, Quarraisha Abdool
Publicado: (2017)

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
por: Burgers, WA, et al.
Publicado: (2012)

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
por: Mahomed, Sharana, et al.
Publicado: (2020)

The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women
por: Abdool Karim, Salim S, et al.
Publicado: (2019)

Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives
por: Baxter, Cheryl, et al.
Publicado: (2021)

Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction
por: Doggett, Elizabeth G, et al.
Publicado: (2015)

The Development of Vaginal Microbicides for the Prevention of HIV Transmission
por: Weber, Jonathan, et al.
Publicado: (2005)

Microbicides: a new hope for HIV prevention
por: Nutan,, et al.
Publicado: (2011)

COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa
por: Abdool Karim, Quarraisha, et al.
Publicado: (2022)

No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial
por: Chopera, Denis R., et al.
Publicado: (2013)

COVID-19 in Africa: Catalyzing change for sustainable development
por: Abdool Karim, Salim S., et al.
Publicado: (2021)

Can a Topical Microbicide Prevent Rectal HIV Transmission?
por: Hladik, Florian, et al.
Publicado: (2008)

Topical microbicides to prevent the transmission of HIV: formulation gaps and challenges
por: Turpin, Jim A.
Publicado: (2011)

Live microbial microbicides for HIV
por: Hamer, Dean, et al.
Publicado: (2006)

Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions
por: McNicholl, Janet M.
Publicado: (2016)

Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
por: Moore, John P
Publicado: (2006)

Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention
por: Miller, Lori, et al.
Publicado: (2022)

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
por: Karim, Quarraisha Abdool, et al.
Publicado: (2011)

Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting
por: Vallely, Andrew, et al.
Publicado: (2012)

Nanotechnology Applications to HIV Vaccines and Microbicides
por: Boyapalle, Sandhya, et al.
Publicado: (2012)

Microbicides and HIV: A Review and an update
por: Naswa, Smriti, et al.
Publicado: (2012)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
por: Nunn, Andrew, et al.
Publicado: (2009)

Update on microbicide research and development-seeking new HIV prevention tools for women
por: Mertenskoetter, T, et al.
Publicado: (2011)

Algal Lectins as Potential HIV Microbicide Candidates
por: Huskens, Dana, et al.
Publicado: (2012)

Microbicides for the Treatment of Sexually Transmitted HIV Infections
por: Singh, Onkar, et al.
Publicado: (2014)

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
por: Gengiah, Tanuja Narayansamy, et al.
Publicado: (2022)

An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana
por: Abdulai, Martha A, et al.
Publicado: (2012)

Use of Pharmacokinetic Data in Novel Analyses to Determine the Effect of Topical Microbicides as Preexposure Prophylaxis Against HIV Infection
por: Vermund, Sten H., et al.
Publicado: (2016)

Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction
por: Lanham, Michele, et al.
Publicado: (2014)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
por: Fisher, Kimone Leigh, et al.
Publicado: (2020)

Improving the large scale purification of the HIV microbicide, griffithsin
por: Fuqua, Joshua L, et al.
Publicado: (2015)

HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities
por: Seaton, Kelly E., et al.
Publicado: (2014)

Where does public funding for HIV prevention go to? The case of condoms versus microbicides and vaccines
por: Peters, Anny JTP, et al.
Publicado: (2010)

Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease
por: Suazo, Paula A., et al.
Publicado: (2014)

Assessing Adherence in the CAPRISA 004 Tenofovir Gel HIV Prevention Trial: Results of a Nested Case–Control Study
por: MacQueen, Kathleen M., et al.
Publicado: (2014)

Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa
por: Kharsany, Ayesha B. M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r7gjl37bsfk6kdsq6n3qp3m3sd